H 
39,750
-7.45%
Close of 3 Nov 2026, in KRW
At a glance
Figures in KRW, as the company reports them.
Revenue
₩172.96bn
FY2020FY2025
Net income
₩72.66bn
FY2020FY2025
Free cash flow
₩97.78bn
FY2020FY2025
Shareholders' equity
₩308.23bn
FY2020FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | ₩172.96bn | ₩181.40bn | ₩179.09bn | ₩159.34bn | ₩91.75bn | ₩61.17bn |
| Gross profit | ₩126.29bn | ₩129.61bn | ₩118.59bn | ₩110.10bn | ₩61.63bn | ₩41.01bn |
| Research and development | ₩12.79bn | ₩11.52bn | ₩4.72bn | ₩5.17bn | ₩4.57bn | ₩4.65bn |
| Operating income | ₩89.90bn | ₩94.03bn | ₩95.15bn | ₩85.17bn | ₩46.80bn | ₩24.79bn |
| Net income | ₩72.66bn | ₩86.28bn | ₩80.43bn | ₩66.01bn | ₩35.34bn | ₩17.66bn |
| Diluted earnings per share | 894.11 | 1,069.82 | 972.41 | 813.29 | 447.39 | 223.98 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Total assets | ₩369.71bn | ₩319.90bn | ₩320.69bn | ₩260.93bn | ₩91.62bn | ₩52.71bn |
| Cash and short-term investments | — | ₩181.29bn | ₩230.40bn | ₩194.01bn | — | — |
| Total liabilities | ₩61.48bn | ₩41.99bn | ₩43.61bn | ₩65.55bn | ₩38.87bn | ₩18.32bn |
| Debt | — | ₩658.6m | ₩1.26bn | ₩2.08bn | — | — |
| Shareholders' equity | ₩308.23bn | ₩277.91bn | ₩277.08bn | ₩195.37bn | ₩52.75bn | ₩34.39bn |
| Shares outstanding | 81m | 81m | 83m | 81m | 79m | 79m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash from operations | ₩100.21bn | ₩83.83bn | ₩66.38bn | ₩82.10bn | ₩37.78bn | ₩32.62bn |
| Capital spending | −₩2.43bn | −₩43.57bn | −₩26.18bn | −₩9.45bn | −₩249.7m | −₩777.5m |
| Free cash flow | ₩97.78bn | ₩40.26bn | ₩40.19bn | ₩72.66bn | ₩37.53bn | ₩31.84bn |
| Dividends paid | −₩48.22bn | −₩7.49bn | −₩1.81bn | — | −₩20.01bn | −₩7.59bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩46.12bn | ₩31.94bn | ₩52.68bn | ₩32.05bn | ₩51.35bn | ₩36.90bn | ₩66.62bn | ₩49.72bn |
| Gross profit | ₩33.47bn | ₩24.92bn | ₩38.81bn | ₩22.60bn | ₩37.86bn | ₩27.01bn | ₩48.82bn | ₩35.59bn |
| Operating income | ₩28.31bn | ₩16.14bn | ₩27.44bn | ₩15.11bn | ₩28.64bn | ₩18.71bn | ₩35.76bn | ₩26.16bn |
| Net income | ₩24.11bn | ₩24.86bn | ₩23.27bn | ₩13.49bn | ₩20.70bn | ₩15.20bn | ₩33.48bn | ₩17.05bn |
| Diluted earnings per share | 296.64 | 305.93 | 286.35 | 167.00 | 256.71 | 188.49 | 416.56 | 212.73 |
| Cash from operations | ₩13.48bn | ₩13.01bn | ₩16.63bn | ₩51.39bn | −₩2.31bn | ₩34.50bn | ₩45.22bn | ₩30.87bn |
| Capital spending | −₩214.0m | −₩321.0m | −₩43.0m | −₩1.69bn | −₩466.0m | −₩226.0m | −₩34.42bn | −₩2.23bn |
| Free cash flow | ₩13.27bn | ₩12.69bn | ₩16.58bn | ₩49.70bn | −₩2.78bn | ₩34.27bn | ₩10.80bn | ₩28.64bn |
| Total assets | ₩407.02bn | ₩392.68bn | ₩369.71bn | ₩339.70bn | ₩299.06bn | ₩345.17bn | ₩319.90bn | ₩289.77bn |
| Cash and short-term investments | — | — | — | — | — | ₩223.86bn | ₩181.29bn | ₩163.39bn |
| Debt | — | — | — | — | — | ₩468.3m | ₩658.6m | ₩727.6m |
| Shareholders' equity | ₩313.46bn | ₩292.87bn | ₩308.23bn | ₩283.88bn | ₩268.99bn | ₩246.70bn | ₩277.91bn | ₩241.76bn |
Financial ratios
Data as of 26 Aug 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 73.0% | 71.5% | 66.2% | 69.1% | 67.2% | 67.0% |
| Operating margin | 52.0% | 51.8% | 53.1% | 53.5% | 51.0% | 40.5% |
| Net margin | 42.0% | 47.6% | 44.9% | 41.4% | 38.5% | 28.9% |
| Return on equity | 23.6% | 31.0% | 29.0% | 33.8% | 67.0% | 51.3% |
| Return on assets | 19.7% | 27.0% | 25.1% | 25.3% | 38.6% | 33.5% |
| Revenue growth | -4.7% | 1.3% | 12.4% | 73.7% | 50.0% | — |
| Earnings growth | -15.8% | 7.3% | 21.9% | 86.8% | 100.2% | — |
| Current ratio | 4.76x | 5.80x | 6.64x | 3.86x | 2.39x | 2.87x |
| Debt to equity | — | 0.00x | 0.00x | 0.00x | — | — |
| Equity ratio | 83.4% | 86.9% | 86.4% | 74.9% | 57.6% | 65.2% |
| Interest coverage | 1516.90x | 920.73x | 557.85x | 485.64x | 270.83x | 129.39x |
| R&D as a share of sales | 7.4% | 6.4% | 2.6% | 3.2% | 5.0% | 7.6% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 3.1% | 23.2% | — |
| Operating income | 1.8% | 29.4% | — |
| Net income | 3.3% | 32.7% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 72.2% | 69.9% | 69.4% | — |
| Operating margin | 51.9% | 52.6% | 51.5% | — |
| Net margin | 44.9% | 44.1% | 42.4% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 37.5 | 24.4 | 45.1 | 16.4 |
| Price to sales | 15.8 | 12.5 | 20.4 | 6.9 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 27 Dec 2023.
| FY2024 | FY2023 | |
|---|---|---|
| Paid in the year | 150.00 | 37.50 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.